2024
Unforeseen and Immediate: A Case of a Post-Watchman Device-Related Thrombus
Sethi S, Stolear A, Dulgher M, Nwokeocha N, Mejia V, Shkolnik E. Unforeseen and Immediate: A Case of a Post-Watchman Device-Related Thrombus. Cureus 2024, 16: e63442. PMID: 39077225, PMCID: PMC11284824, DOI: 10.7759/cureus.63442.Peer-Reviewed Original ResearchDevice-related thrombusLeft atrial appendageOral anticoagulantsLAA occlusionLong-term oral anticoagulationAssociated with increased morbidityLeft atrial appendage occlusionHeparin dripPeriprocedural managementPrompt diagnosisThrombus resolutionSafety profileRare caseWatchman deviceArterial thromboembolismAtrial fibrillationAtrial appendageLeft atriumPersistent AFibAtrial sideRisk factorsBlood clot formationThrombusPatientsTherapeutic interventions
2022
High Altitude Induced Thrombosis: Challenges and Recent Advancements in Pathogenesis and Management
Tyagi T, Jain K. High Altitude Induced Thrombosis: Challenges and Recent Advancements in Pathogenesis and Management. 2022, 85-101. DOI: 10.1007/978-981-19-1008-1_6.ChaptersMolecular pathogenesisAvailable treatment optionsBlood clot formationPulmonary embolismVenous thrombosisTreatment optionsClinical managementRisk factorsAnimal studiesHigh-altitude hypoxic environmentClot formationSerious disorderPathogenesisThrombosisHypoxic environmentVTEDisordersNumber of humanEmbolism
2019
Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway
Kitay AM, Ferstl FS, Link A, Geibel JP. Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway. Frontiers In Physiology 2019, 10: 1264. PMID: 31649553, PMCID: PMC6795678, DOI: 10.3389/fphys.2019.01264.Peer-Reviewed Original ResearchGastric acid secretionNon-selective NOS inhibitor L-NAMENOS inhibitor L-NAMEInhibitor L-NAMEAcid secretionL-NAMESoluble guanylyl cyclase inhibitor 1HGuanylyl cyclase inhibitor 1HIncreases nitric oxide productionUsage of aspirinGastric glandsPH-sensitive dye BCECF-AMNitric oxide productionVariety of cancersNovel secretagogueBlood clot formationAspirin exposureChronic conditionsMucosal barrierRepetitive dosesUlcer formationAspirin consumptionBasolateral exposureAspirinClot formation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply